Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Avellino
Clinical trial register · Italy

Clinical Trials in Avellino, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Italiana Linfomi - ETS11 AstraZeneca5 Gruppo Italiano Malattie EMatologiche dell'Adulto3 Hoffmann-La Roche3 Mirati Therapeutics Inc.3
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Avellino

67 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
BV-CHP Real-life and Biological Evidences in Patients With sALCL
NCT07467317Anaplastic Large Cell Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
100
Avellino, Aviano, Bari, Bergamo, Bologna, Candiolo, Legnano, Milan
2026-09
Not yet open
Heart Care Foundation
Phase 3
600
Acquaviva delle Fonti, Altamura, Arezzo, Avellino, Bari, Casale Monferrato, Caserta, Catania
2026-09
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
518
Alessandria, Avellino, Aviano, Bergamo, Brescia, Cagliari, Candiolo, Catania
2026-07-10
Not yet open
Fondazione Italiana Linfomi - ETS
Not applicable
170
Ancona, Avellino, Aviano, Bari, Brescia, Cagliari, Florence, Milan
2026-05
Not yet open
Fondazione Italiana Linfomi - ETS
Phase 2
56
Meldola, Rozzano, Ancona, Avellino, Biella, Bologna, Brescia, Catania
2026-02-01
Recruiting
Novartis Pharmaceuticals
Observational
50
Alessandria, Avellino, Brescia, Florence, Genova, Milan, Palermo, Roma
2026-01-13
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Castellana Grotte, San Giovanni Rotondo, Tricase, Milan, Aviano, Pisa, Padova, Avellino
2025-12-31
Recruiting
Janssen Research & Development, LLC
Observational
380
Avellino, Aviano, Bari, Bergamo, Brescia, Candiolo, Catania, Catanzaro
2025-12-03
Recruiting
RESOLving INflammation Through Diet for Health (RESOLVIN)
NCT07331103Cardiovascualr Disease, Lipids, Inflammation, n-3 Polyunsatured Fatty Acids (n-3 PUFA)
Mario Negri Institute for Pharmacological Research
Not applicable
324
Avellino, Arese, Milan, Paderno Dugnano, Matera
2025-11-26
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Ravenna, Aviano, Orbassano, Candiolo, Avellino, Milan, Naples, Parma
2025-11-05
Recruiting
University of Campania Luigi Vanvitelli
Phase 3
480
Ancona, Avellino, Aviano, Bari, Brescia, Castellana Grotte, Catania, Catanzaro
2025-10-01
Active, closed
AstraZeneca
Observational
315
Cittadella (PD), Montebelluna (TV), Aosta, Avellino, Bari, Bergamo, Brescia, Cagliari
2025-06-25
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
47
Alessandria, Pescara, Ancona, Avellino, Aviano, Brescia, Florence, Milan
2025-04-09
Recruiting
BRCA Mutation Carriers' Platform a Multicenter Study
NCT07253051BRCA1 Mutation, BRCA2 Mutation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
10,000
Avellino, Aviano, Bari, Bergamo, Catania, Cuneo, Enna, Florence
2025-04-05
Active, closed
Immutep S.A.S.
Phase 3
756
Avellino, Aviano, Candiolo, Milan, Naples, Perugia, Reggio Emilia, Terni
2025-03-21
Recruiting
National Cancer Institute, Naples
Phase 2
130
Caserta, Naples, Avellino, Udine, Tricase, Frattamaggiore, Pozzuoli
2025-03-12
Not yet open
Consorzio Oncotech
Observational
1,000
Avellino, Bergamo, Bologna, Brescia, Termoli, Caserta, Cuneo, Ferrara
2025-03
Recruiting
Tensi+ European Registry
NCT07205445Overactive Bladder
Stimuli Technology
Observational
500
Avellino, Florence, Modena, Montevarchi, Roma
2025-02-27
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Acquaviva delle Fonti, Ancona, Avellino, Bari, Bolzano, Brescia, Casale Monferrato, Caserta
2025-02-12
Recruiting
BioNTech SE
Phase 3
621
Avellino, Aviano, Cremona, Lucca, Meldola, Monza, Naples, Peschiera del Garda
2025-02-03
Recruiting
BioNTech SE
Phase 2/3
1,580
Avellino, Aviano, Bologna, Candiolo, Catania, Cona, Cremona, Lucca
2025-01-07
Recruiting
Bayer
Phase 3
555
Avellino, Aviano, Bologna, Florence, Lecce, Meldola, Milan, Orbassano
2024-08-28
Recruiting
Continuous Glucose Monitoring in HIE
NCT06563687Hypoxic Ischemic Encephalopathy of Newborn, Hyperglycemia, Hypoglycemia
University of Campania Luigi Vanvitelli
Not applicable
70
Avellino, Naples
2024-08-01
Recruiting
Fondazione Oncotech
Observational
300
Avellino, Ancona, Aviano, Bari, Barletta, Bergamo, Caserta, Genova
2024-07-01
Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
NCT06749600Primary Ovarian Leiomyosarcoma
Azienda USL Reggio Emilia - IRCCS
Observational
30
Modena, Parma, Reggio Emilia, Avellino, Catania, Milan, Monza, Naples
2024-06-14
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
56
Avellino, Alessandria, Biella, Milan, Novara, Pavia, Piacenza, Torino
2024-05-07
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
130
Alessandria, Ancona, Avellino, Aviano, Brescia, Castelfranco Veneto, Florence, Milan
2024-04-18
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
1,500
Viagrande, Pescia, Alessandria, Ancona, Avellino, Aviano, Bari, Barletta
2023-12-27
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
190
Sassuolo, Alessandria, Avellino, Aviano, Bari, Biella, Brescia, Cagliari
2023-12-14
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Brindisi, Avellino, Naples, Bologna, Meldola, Parma, Aviano (PN), Udine
2023-12-11
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Exemestane·Anastrozole·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
510
Avellino, Bologna, Meldola, Modena, Reggio Emilia, Udine, Rome, Milan
2023-11-16
Recruiting
Surgical TReatment of Women With Deep ENDometriosis
NCT06386276Deep Endometriosis, Surgery
Casa di Cura Privata 'Malzoni - Villa dei Platani' S.P.A.
Observational
250
Avellino
2023-10-11
Recruiting
The ONCOCAMP Study
NCT06270602Oncology
National Cancer Institute, Naples
Observational
15,000
Avellino, Benevento, Caserta, Casavatore, Ercolano, Naples, Salerno
2023-07-14
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Acquaviva delle Fonti, Asti, Avellino, Castelfranco Veneto, Milan, Naples, Ravenna, Rome
2023-03-23
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 1/2
122
Alessandria, Candiolo, Avellino, Aviano, Bari, Brescia, Lecce, Meldola
2023-02-27
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
1,000
Aviano, Ancona, Avellino, Brindisi, Catania, Genova, Mantua, Meldola
2022-12-03
Active, closed
Mirati Therapeutics Inc.
Phase 2
90
Avellino, Casale Monferrato, Florence, Milan, Orbassano, Ravenna, Roma
2022-11-22
Recruiting
Associazione Qol-one
Phase 2
22
Alessandria, Ancona, Avellino, Biella, Catania, Chivasso, Cosenza, Florence
2022-11-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
80
Avellino, Bassano del Grappa, Florence, Milan, Reggio Calabria, Roma
2022-10-28
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Monserrato, Avellino, Rome, Tricase, Brescia, Milan, Naples, Verona
2022-10-24
Active, closed
GlaxoSmithKline
Phase 2
351
Avellino, Bergamo, Genova, Pisa, Verona
2022-10-14
Active, closed
Gilead Sciences
Phase 3
1,021
Avellino, Cremona, Genova, Milan, Naples, Pavia, Pesaro, Piacenza
2022-10-12
Active, closed
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
NCT05306301Chemotherapy, Leukemia, Acute Lymphoblastic
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
32
Avellino, Pagani, Bergamo, Bologna, Brescia, Catania, Florence, Lecce
2022-10-05
Active, closed
AstraZeneca
Phase 3
341
Avellino, Aviano, Catania, Meldola, Milan, Modena, Monserrato, Naples
2022-08-03
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
NCT06822855Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS
Observational
755
Milan, Reggio Emilia, Avellino, Brescia, Padova, Palermo, Perugia, Piacenza
2022-06-23
Active, closed
Sanofi
Phase 2
22
Avellino, Meldola, Milan
2021-12-07
Active, closed
AstraZeneca
Phase 3
148
Arezzo, Avellino, Bari, Bologna, Florence, Meldola, Milan, Naples
2021-10-28
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Avellino, Naples, Bologna, Meldola, Reggio Emilia, Roma, Milan, Rozzano (MI)
2021-08-27
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Ascoli Piceno, Avellino, Florence, Milan, Roma, Torino, Bassano del Grappa
2021-07-27
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Avellino, Biella, Cagliari, Candiolo, Lido di Camaiore, Meldola, Milan, Naples
2021-06-24
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Avellino, Naples, Modena, Aviano, Rome, Brescia, Milan, Livorno
2021-05-04
Active, closed
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
NCT04475731Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
67
Ancona, Ascoli Piceno, Avellino, Bari, Bergamo, Bologna, Brescia, Cuneo
2021-05-04
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Alessandria, Avellino, Aviano, Bari, Brescia, Candiolo, Catania, Florence
2021-02-23
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Acquaviva delle Fonti, Agrigento, Ancona, Anzio, Ariccia, Ascoli Piceno, Avellino, Avezzano
2021-01-15
Active, closed
GlaxoSmithKline
Phase 2/3
758
Ancona, Avellino, Florence, Milan, Monza, Naples, Orbassano to, Perugia
2020-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Avellino, Catania, Meldola, Milan, Monza, Naples, Orbassano, Ravenna
2020-09-30
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
414
Alessandria, Ancona, Ascoli Piceno, Avellino, Bari, Bologna, Caserta, Castelfranco Veneto
2020-09-24
Active, closed
Nouscom SRL
Phase 1/2
115
Avellino, Candiolo, Milan, Siena
2019-10-21
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Bari, Carbonara di Bari, Catanzaro, Avellino
2019-10-03
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
75
Castelfranco Veneto, Alessandria, Ancona, Avellino, Aviano, Bari, Brescia, Cagliari
2019-07-02
Active, closed
AstraZeneca
Phase 2
367
Avellino, Florence, Milan, Orbassano, Padova, Parma, Perugia, Peschiera del Garda
2019-01-09
Active, closed
National Register of Actionable Mutations
NCT05918666Solid Tumours in Advanced Stages
Federation of Italian Cooperative Oncology Groups
Observational
2,098
Ancona, Arezzo, Avellino, Aviano, Bari, Bergamo, Brindisi, Catania
2018-10-27
Active, closed
AbbVie
Phase 2
270
Bologna, Meldola, Milan, Naples, Rome, Orbassano, Avellino, Parma
2018-10-10
Active, closed
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Phase 3
1,000
Casale Monferrato, Fabriano, Avellino, Bari, Bergamo, Treviglio, Benevento, Brindisi
2013-06
Active, closed
Associazione Qol-one
Phase 2
174
Alessandria, Ancona, Asti, Avellino, Bari, Brindisi, Cagliari, Cosenza
2011-06-11
Recruiting
Manuel Monreal
Observational
120,000
Avezzano, Belluno, Brescia, Avellino, Naples, Marcianise, Castelfranco, Cremona
2001-03
Rows per page Showing 1–67 of 67
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/avellino

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 67 of those studies with a site in Avellino.

How many clinical trials are recruiting in Avellino?

28 of the 67 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 5 have not yet opened recruitment, 34 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Avellino), 67 studies
PhaseStudiesRecruitingShare
Phase 323734.3%
Observational201329.9%
Phase 214320.9%
Not applicable426%
Phase 2/3436%
Phase 1/2203%

Most active sponsors

Lead sponsors with the most studies (Avellino)
Lead sponsorStudiesRecruiting
Fondazione Italiana Linfomi - ETS115
AstraZeneca50
Gruppo Italiano Malattie EMatologiche dell'Adulto31
Hoffmann-La Roche30
Janssen Research & Development, LLC31
Mirati Therapeutics Inc.30
Associazione Qol-one21
Azienda USL Reggio Emilia - IRCCS22
BioNTech SE22
Bristol-Myers Squibb22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.